Thus, restoration of BRCA1/2 tumor suppressor activities through intracellular delivery of BRCA1/2 gene with the aid of CA NPs, suggestively repressed breast tumor growth both in vitro and in vivo, supporting the concept that BRCA1/2 might be the possible targets for gene-based therapy of breast cancer. Here, BRCA1 is linked to breast carcinoma.